These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37886935)

  • 1. Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer.
    Gökmen İ; Taştekin E; Demir N; Özcan E; Akgül F; Hacıoğlu MB; Erdoğan B; Topaloğlu S; Çiçin İ
    Curr Issues Mol Biol; 2023 Sep; 45(10):7803-7812. PubMed ID: 37886935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between clinicopathological features and
    Zhu X; Meng X; Xiang W; Dai W; Bai Q; Sheng W; Lu Y; Qi P; Wu L; Cai G; Zhou X
    Int J Clin Exp Pathol; 2018; 11(5):2839-2845. PubMed ID: 31938404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
    Ta TV; Nguyen QN; Chu HH; Truong VL; Vuong LD
    Pathol Res Pract; 2020 Apr; 216(4):152898. PubMed ID: 32089414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Somatic Mutations in RAS/RAF/MAPK Signaling Pathway in Moroccan and North African Colorectal Cancer Patients.
    Benmokhtar S; Laraqui A; El Boukhrissi F; Hilali F; Bajjou T; Jafari M; El Zaitouni S; Baba W; El Mchichi B; Elannaz H; Lahlou IA; Chahdi H; Oukabli M; Mahfoud T; Tanz R; Ichou M; Ennibi K; Dakka N; Sekhsokh Y
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3725-3733. PubMed ID: 36444585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer.
    Saharti S
    Cureus; 2022 Apr; 14(4):e24392. PubMed ID: 35619874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.
    Shen Y; Wang J; Han X; Yang H; Wang S; Lin D; Shi Y
    PLoS One; 2013; 8(12):e81628. PubMed ID: 24339949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.
    Negru S; Papadopoulou E; Apessos A; Stanculeanu DL; Ciuleanu E; Volovat C; Croitoru A; Kakolyris S; Aravantinos G; Ziras N; Athanasiadis E; Touroutoglou N; Pavlidis N; Kalofonos HP; Nasioulas G
    BMJ Open; 2014 May; 4(5):e004652. PubMed ID: 24859998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between
    Bożyk A; Krawczyk P; Reszka K; Krukowska K; Kolak A; Mańdziuk S; Wojas-Krawczyk K; Ramlau R; Milanowski J
    Arch Med Sci; 2022; 18(5):1221-1230. PubMed ID: 36160343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.
    Chen J; Guo F; Shi X; Zhang L; Zhang A; Jin H; He Y
    BMC Cancer; 2014 Nov; 14():802. PubMed ID: 25367198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients.
    Mosaferi Z; Pirestani M; Arefian E; Gojani G; Kavousinasab N; Karimi P; Deilami A; Abrehdari-Tafreshi Z
    J Gastrointest Cancer; 2024 Sep; 55(3):1134-1143. PubMed ID: 38709419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor profiling of KRAS, BRAF, and NRAS gene mutations in patients with colorectal cancer: A Lebanese major center cohort study.
    Baba O; Bidikian A; Mukherji D; Shamseddin A; Temraz S; Fakhruddin N; Khazzouh M; Ghizzawi D; Abdel Khalek R; Zaatari G; Mahfouz R
    Gene; 2022 Aug; 834():146646. PubMed ID: 35680020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
    Ikoma T; Shimokawa M; Kotaka M; Matsumoto T; Nagai H; Boku S; Shibata N; Yasui H; Satake H
    BMC Cancer; 2021 May; 21(1):518. PubMed ID: 33962575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
    Gao J; Sun ZW; Li YY; Shen L
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
    De Roock W; Claes B; Bernasconi D; De Schutter J; Biesmans B; Fountzilas G; Kalogeras KT; Kotoula V; Papamichael D; Laurent-Puig P; Penault-Llorca F; Rougier P; Vincenzi B; Santini D; Tonini G; Cappuzzo F; Frattini M; Molinari F; Saletti P; De Dosso S; Martini M; Bardelli A; Siena S; Sartore-Bianchi A; Tabernero J; Macarulla T; Di Fiore F; Gangloff AO; Ciardiello F; Pfeiffer P; Qvortrup C; Hansen TP; Van Cutsem E; Piessevaux H; Lambrechts D; Delorenzi M; Tejpar S
    Lancet Oncol; 2010 Aug; 11(8):753-62. PubMed ID: 20619739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience.
    Baltruškevičienė E; Mickys U; Žvirblis T; Stulpinas R; Pipirienė Želvienė T; Aleknavičius E
    Acta Med Litu; 2016; 23(1):24-34. PubMed ID: 28356789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma].
    Zhang K; Xu J; Yan L; Liu X; Xu F; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):254-7. PubMed ID: 25975908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation Status and Immunohistochemical Correlation of
    Yang Q; Huo S; Sui Y; Du Z; Zhao H; Liu Y; Li W; Wan X; Liu T; Zhang G
    Front Oncol; 2018; 8():487. PubMed ID: 30416987
    [No Abstract]   [Full Text] [Related]  

  • 18. Demographic trends and KRAS/BRAF
    Fu X; Huang Y; Fan X; Deng Y; Liu H; Zou H; Wu P; Chen Z; Huang J; Wang J; Lin H; Huang S; Tan X; Lan P; Wang L; Wang JP
    Int J Cancer; 2019 May; 144(9):2109-2117. PubMed ID: 30414169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients.
    Mirzapoor Abbasabadi Z; Hamedi Asl D; Rahmani B; Shahbadori R; Karami S; Peymani A; Taghizadeh S; Samiee Rad F
    J Clin Lab Anal; 2023 Mar; 37(5):e24868. PubMed ID: 36930789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between mismatch repair protein,
    Fan JZ; Wang GF; Cheng XB; Dong ZH; Chen X; Deng YJ; Song X
    World J Clin Cases; 2021 Apr; 9(11):2458-2468. PubMed ID: 33889611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.